Cme Group Stock Return On Asset
| CHME34 Stock | BRL 325.51 0.00 0.00% |
CME Group fundamentals help investors to digest information that contributes to CME's financial success or failures. It also enables traders to predict the movement of CME Stock. The fundamental analysis module provides a way to measure CME's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CME stock.
CME |
CME Group Company Return On Asset Analysis
CME's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current CME Return On Asset | 0.0102 |
Most of CME's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CME Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, CME Group has a Return On Asset of 0.0102. This is 102.17% lower than that of the Financial Services sector and significantly higher than that of the Financial Data & Stock Exchanges industry. The return on asset for all Brazil stocks is 107.29% lower than that of the firm.
CME Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CME's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CME could also be used in its relative valuation, which is a method of valuing CME by comparing valuation metrics of similar companies.CME is currently under evaluation in return on asset category among its peers.
CME Fundamentals
| Return On Equity | 0.0992 | |||
| Return On Asset | 0.0102 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.60 % | |||
| Current Valuation | 341.49 B | |||
| Shares Outstanding | 1.44 B | |||
| Price To Earning | 10.55 X | |||
| Price To Book | 2.27 X | |||
| Price To Sales | 69.07 X | |||
| Revenue | 5.02 B | |||
| Gross Profit | 5.02 B | |||
| EBITDA | 4.02 B | |||
| Net Income | 2.69 B | |||
| Cash And Equivalents | 1.19 B | |||
| Cash Per Share | 3.32 X | |||
| Total Debt | 3.42 B | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 1.02 X | |||
| Book Value Per Share | 18.72 X | |||
| Cash Flow From Operations | 2.4 B | |||
| Earnings Per Share | 9.62 X | |||
| Price To Earnings To Growth | 4.61 X | |||
| Number Of Employees | 37 | |||
| Beta | 0.41 | |||
| Market Capitalization | 347.39 B | |||
| Total Asset | 174.18 B | |||
| Z Score | 60.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 174.18 B | |||
| Last Dividend Paid | 4.0 |
About CME Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CME Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CME using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CME Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in CME Stock
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.